School of Medicine
Showing 51-60 of 143 Results
-
Prasanna Jagannathan
Associate Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsWe study innate immunity and immune regulation of Plasmodium Falciparum malaria in children and pregnant women. Our work focuses on understanding how malaria shapes the immune state in individuals following repeated exposure. We are also testing novel interventions to enhance protective immunity against malaria in children via large, randomized controlled trials. Our work in malaria has been based in Eastern Uganda, where malaria transmission is among the highest in the world.
-
Shanthi Kappagoda
Clinical Associate Professor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsCompleted a Masters degree in Health Services Research in 2012. Research focused on using network models to develop a clinical research agenda for neglected tropical diseases.
-
Abraar Karan, MD MS MPH DTM&H
Instructor, Medicine - Infectious Diseases
BioI am an Instructor in the Division of Infectious Diseases and Geographic Medicine with affiliations in the Center for Innovation in Global Health, the King Center on Global Development, and the Woods Institute for the Environment. I worked on the Covid19 outbreak for the Massachusetts Department of Public Health in 2020, and the Monkeypox outbreak for the Los Angeles County Department of Public Health in 2022-23. I also served on the WHO-commissioned Independent Panel on Pandemic Preparedness and Response's research team investigating early global spread of Covid19, and helped with policy-writing for the Biden-Harris campaign on reducing Covid19 in schools. I am currently the Principal Investigator of the following studies: a cluster-randomized controlled trial investigating whether air filtration and ventilation can reduce spread of Covid19 in low-income homes in the Bay Area (https://clinicaltrials.gov/ct2/show/NCT05777720); utilizing multiplex assays for detecting exposures to filoviruses in Western Kenya; and assessing H5N1 seroprevalence in high-risk farmworker communities in California. I am also a co-investigator on a study focused on rtPCR based surveillance of H5N1 in humans in Central California.
I completed my internal medicine residency at the Brigham and Women's Hospital/Harvard Medical School in the Global Health Equity program, and have been working in global health since 2008. I co-edited the book, "Protecting the Health of the Poor" (December 2015, Bloomsbury Publishing, https://www.bloomsbury.com/us/protecting-the-health-of-the-poor-9781783605521/); and co-founded Longsleeve insect repellent, winner of the 2018 Harvard Business School New Venture Competition and finalist in the 2019 Harvard President's Challenge. Media/press coverage has included NBC, ABC, BBC, PBS, CBS, CNN, MSNBC, Fox News, Washington Post, New York Times, SF Chronicle, Bloomberg, Boston Globe, ProPublica, WSJ, TIME, Politico, CBC News, Democracy Now, NPR, ESPN, The Atlantic, The Hill, Business Insider, Vice, Mother Jones, Vox, Forbes, Slate, STAT News, MTV News, Mother Jones, Science Friday, TMZ.
For a full list of publications, please see "Publications" tab. For full list of press/media interviews, please see "Media" link.
Teaching Experience:
Teaching Assistant-- Epi 231, Infectious Disease Epidemiology (Winter 2024)
Teaching Assistant-- Epi 237, Practical Approaches to Global Health Research (Autumn 2024)
Teaching Assistant-- Epi 231, Infectious Disease Epidemiology (Winter 2025) -
MD Emranul Karim
Affiliate, Medicine - Med/Infectious Diseases
Visiting Postdoctoral Scholar, Medicine - Med/Infectious DiseasesBioDr. Md. Emranul Karim is a Visiting Postdoctoral Scholar in the Department of Medicine, Division of Infectious Diseases & Geographic Medicine at Stanford University, working in the laboratory of Prof. Paul Bollyky. His current research focuses on RNA therapeutics and innovative delivery strategies for infectious and immune-mediated diseases.
Before joining Stanford, Dr. Karim was a Postdoctoral Associate in the Department of Chemical Engineering at the Massachusetts Institute of Technology (MIT), where he worked with Prof. Allan S. Myerson on developing continuous manufacturing platforms for in vitro transcription (IVT) of messenger RNA. His training at MIT provided expertise in mRNA synthesis, process optimization, and scalable manufacturing.
Dr. Karim’s broader research background lies in nanoparticle-based drug delivery and translational nanomedicine. He has extensive experience in the design and characterization of lipid nanoparticles (LNPs) and hybrid nanocarriers for nucleic acid delivery, with applications in vaccines, oncology, and regenerative medicine. He earned his Ph.D. in Biomedical Sciences from Monash University, where he developed novel nanoparticle platforms for targeted drug and gene delivery to breast cancer.
His long-term vision is to bridge RNA manufacturing and next-generation delivery technologies to accelerate the clinical translation of nucleic acid–based medicines.
